COMMUNIQUÉS West-GlobeNewswire

Ultragenyx to Present at Bank of America Merrill Lynch Healthcare Conference
10/05/2019
NOVATO, Calif., May 10, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, [...]
Intercept Pharmaceuticals Announces Pricing of Offerings of Common Stock and Convertible Senior Notes due 2026
10/05/2019
NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral [...]
Cormedix Announces Presentation of LOCK-IT-100 Study Results at National Kidney Foundation Spring 2019 Meeting
10/05/2019
BERKELEY HEIGHTS, N.J., May 10, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment [...]
Genetic Technologies Limited (ASX Code: GTG; NASDAQ Ticker: GENE) announces successful completion of two new ground-breaking Genetic Risk Tests – for Colorectal Cancer and for Breast Cancer
10/05/2019
MELBOURNE, Australia, May 10, 2019 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ Ticker: GENE) is delighted to announce that following substantial scientific research and genetic product development [...]
Bladder Cancer Canada celebrates ten years
10/05/2019
The extraordinary efforts of two bladder cancer survivors ten years ago has resulted in a national organization dedicated to supporting patients and their caregivers – and significant efforts to bring an end to the 5th [...]
Cancer de la vessie Canada célèbre son 10e anniversaire
10/05/2019
Les efforts assidus déployés par deux survivants du cancer de la vessie il y a 10 ans ont mené à un organisme national dédié au soutien des patients et de leurs aidants dont l’objectif est de mettre un terme au [...]
Galectin Therapeutics Releases Richard E. Uihlein’s Open Letter to Stockholders Dated May 10, 2019
10/05/2019
NORCROSS, Ga., May 10, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today released this open letter to stockholders written by [...]
Forty Seven Inc. and Acerta Enter Collaboration to Evaluate Novel Immuno-Oncology Triple Combination in Diffuse Large B-cell Lymphoma
10/05/2019
-- Plan to evaluate Forty Seven’s CD47 antibody in combination with rituximab and Calquence (acalabrutinib) -- -- Novel combination aims to leverage the macrophage component of the innate immune system and a targeted [...]
Allscripts to present at Bank of America Merrill Lynch 2019 Healthcare Conference
10/05/2019
CHICAGO, May 10, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) today announced that certain members of its management team will present at the 2019 Bank of America Merrill Lynch Healthcare Conference, to be held [...]
Galectin Therapeutics Reports Q1 2019 Financial Results and Provides Business Update
10/05/2019
Subscription rights to purchase Galectin Therapeutics, Inc. common shares, with accompanying warrants, mailed to Holders of Record as of April 29. Rights expire at 5:00 PM Eastern on May 23, 2019 Portion of the Net [...]
Immutep Announces Upcoming Industry Conference Participation
10/05/2019
SYDNEY, Australia, May 10, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]
Crown Bioscience annonce une expansion de son site de San Diego, en Californie
10/05/2019
Création d'un Centre d'excellence international pour l'offre de services translationnels dans les domaines des inflammations et des biomarqueurs en oncologie SAN DIEGO, 10 mai 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, [...]
Flexion Therapeutics Announces Publication of Pooled Analysis of Phase 2/3 Data on Use of Rescue Medication with ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)
10/05/2019
Pooled analysis published in Pain and Therapy indicated that the number of rescue medication tablets used per day through Week 24 was significantly less for ZILRETTA versus placebo and triamcinolone acetonide [...]
Wave Life Sciences Reports First Quarter 2019 Financial Results and Provides Business Update
10/05/2019
CAMBRIDGE, Mass., May 10, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating [...]
Acasti Settles Claims with Former Chief Executive Officer
10/05/2019
LAVAL, Québec, May 10, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), today announced that it has settled regarding claims made against the Company by its former [...]
Mustang Bio Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
10/05/2019
NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]
Fortress Biotech Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
10/05/2019
NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and [...]
Organogenesis Holdings Inc. Reports First Quarter 2019 Financial Results
10/05/2019
CANTON, Mass., May 10, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for [...]
MediPharm Labs Announces Q1 2019 Revenue of $22 Million and Adjusted EBITDA of $4.3 Million
10/05/2019
TORONTO, May 10, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation [...]

Pages